Trial Profile
Elucidation of acid-induced pulmonary inflammation.
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Gastro-oesophageal reflux; Heartburn
- Focus Therapeutic Use
- 12 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2009 Actual number of patients (36) added as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.